Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash

Inclusion Criteria: * Male or Female 18-80 years of age * Twelve months or more of allergic rhinitis symptoms * Allergic antibodies to perennial aeroallergens to be confirmed by blood draw Exclusion Criteria: * Intranasal or systemic glucocorticosteroids within one month of study entry * Intranasal cromolyn for 2 weeks prior to study * Intranasal or systemic antihistamine for 3 days prior to the study * Loratadine for ten days prior to study * History of rhinitis medicamentosa * Planned travel outside the study area that will inhibit study follow-up visits \_Persons with Asthma with more than 2 episodes per week or month of nighttime awakenings * Persons with Known sensitivity to Calcium or phosphorus supplements * Persons taking antihistamine treatment intermittently. (Chronic steady use throughout study is acceptable) * Immunomodulatory or cytotoxic drugs * Clinically significant uncontrolled disease that in the opinion of the investigator would put the subject at risk or may confound the study interpretation * Persons with hypercalcemia * Persons whose nasal obstruction(s) would be significant to obstruct air flow * Persons who are employees of Investigator or AkPharma or whose spouse, parent, child or sibling is employee of investigator * Pregnant persons or persons planning to conceive/inseminate partner during study or for one month after